Skip to Content
Also part of the UPMC family:
Monoclonal Antibodies Consumer Banner
Monoclonal Antibodies Consumer Mobile Banner

Paxlovid™: A Treatment Option for COVID-19

Paxlovid™

Paxlovid™, an oral antiviral medication, is available for treatment of mild to moderate COVID-19, and available at retail pharmacies with a prescription.

Paxlovid can help patients with mild to moderate COVID-19 avoid severe outcomes, including hospitalization or death.

To qualify for Paxlovid, you must have tested positive for COVID-19, and treatment must begin within five days of the start of your symptoms. Other qualifications for Paxlovid include:

  • You must be 12 years old or older.
  • Weigh at least 88 pounds.
  • Have mild to moderate COVID-19.
  • Be at high risk for severe COVID-19.

You can receive Paxlovid from a pharmacy if you have a prescription.

How are antibodies made?

Antibodies are proteins made by your body's immune system that fight off infections, including infections caused by viruses. Your body can remember how to make antibodies if you are exposed to the same germ again.

COVID-19 Treatment: Frequently Asked Questions

Can I get a COVID-19 vaccine if I have had treatment?

If you received Paxlovid for treatment of COVID-19, you can receive a COVID-19 vaccine as soon as you are clinically well (recovered) and considered no longer contagious. Contact your doctor to learn more about when you are considered no longer contagious and able to come to vaccine clinic.

Can you receive Paxlovid if you already received the COVID-19 vaccine?

Yes. If you get COVID-19 and meet criteria for Paxlovid, you can it receive it.

Information about Monoclonal Antibody Pre-Exposure Prophylaxis for Immunocompromised Patients

Evusheld is a potent new COVID-19 protective measure (monoclonal antibody) designed to prevent COVID-19 infection in vulnerable and immunocompromised individuals.

Learn more about this medication.